loadpatents
Patent applications and USPTO patent grants for Clanotech AB.The latest application filed is for "quinoline compounds which are anti-angiogenic integrin alpha5 beta1 inhibitors for use in the treatment of fibrosis or fibrosis-related diseases".
Patent | Date |
---|---|
Quinoline compounds which are anti-angiogenic integrin alpha5 beta1 inhibitors for use in the treatment of fibrosis or fibrosis-related diseases Grant 9,376,393 - Cao June 28, 2 | 2016-06-28 |
Quinoline derivatives and their use as tyrosine kinase inhibitors Grant 8,957,092 - Westman , et al. February 17, 2 | 2015-02-17 |
Quinoline Compounds Which Are Anti-Angiogenic Integrin Alpha5 Beta1 Inhibitors for Use in the Treatment of Fibrosis or Fibrosis-Related Diseases App 20150031723 - Cao; Yihai | 2015-01-29 |
Quinoline derivatives and their use as tyrosine kinase inhibitors Grant 8,557,843 - Westman , et al. October 15, 2 | 2013-10-15 |
Substituted Quinolines For Use As Vegf Inhibitors App 20120065199 - Malm; Johan ;   et al. | 2012-03-15 |
Quinoline Derivatives And Their Use As Tyrosine Kinase Inhibitors App 20110053976 - Westman; Jacob ;   et al. | 2011-03-03 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.